An official from the National Development and Reform Commission (NDRC) revealed that 80% of the more than 300 types of original drugs from foreign companies supervised by government agencies are really higher than peers in South Korea, Hong Kong and Taiwan but 70% are lower than those in Europe, US and Japan in terms prices. Hong Kong has no 5% tariff and 17% value-added tax, no 15% price markup from hospitals and circulation expenses surpassing as much as 20%, certainly has higher drug prices.
Source:
http://www.sinocast.com/readbeatarticle.do?id=99205
